Basics Capricor Therapeutics, Inc. Capricor Therapeutics Inc is a clinical stage biotechnology company developing products for the treatment of cardiovascular diseases with a focus on heart failure. IPO Date: March 1, 2007 Sector: Healthcare Industry: Biotech Market Cap: $327.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 3.95% Avg Daily Range (30 D): $0.57 | 5.48% Avg Daily Range (90 D): $0.60 | 5.70% Institutional Daily Volume Avg Daily Volume: .64M Avg Daily Volume (30 D): 3.02M Avg Daily Volume (90 D): 2.32M Trade Size Avg Trade Size (Sh.): 186 Avg Trade Size (Sh.) (30 D): 132 Avg Trade Size (Sh.) (90 D): 112 Institutional Trades Total Inst.Trades: 306 Avg Inst. Trade: $1.35M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.13M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.5M Avg Closing Trade (30 D): $1.32M Avg Closing Trade (90 D): $1.24M Avg Closing Volume: 127.25K     News Jul 22, 2025 @ 6:57 PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Capric... Source: Rosen Law Firm Jul 19, 2025 @ 2:31 PM CAPRICOR ALERT: Bragar Eagel & Squire, P.C. Announ... Source: Bragar Eagel & Squire, P.C. Jul 18, 2025 @ 5:50 PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ... Source: James (Josh) Wilson Jul 18, 2025 @ 4:56 PM CAPRICOR THERAPEUTICS, INC. (NASDAQ: CAPR) INVESTO... Source: Bernstein Liebhard Llp Jul 17, 2025 @ 10:37 PM Shareholder Alert: Robbins LLP Informs Investors o... Source: Robbins Llp Financials   TTM Q4 2024 FY 2024 Basic EPS $-.53 $-.11 $-1.15 Diluted EPS $-.53 $-.11 $-1.15 Revenue $ M $ 11.13M $ 22.27M Gross Profit $ $ $ Net Income / Loss $ -24.39M $ -7.12M $ -40.47M Operating Income / Loss $ -24.98M $ -7.7M $ -42.56M Cost of Revenue $ $ $ Net Cash Flow $ 17.51M $ -57.09M $ -3.41M PE Ratio     Splits Jun 05, 2019:   1:10 Nov 21, 2013:   1:50 Feb 09, 2007:   1:10 Apr 05, 2005:   1:20